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STRUCTURED ABSTRACT  
Aim: To investigate the cytotoxicity and estrogenicity of Vivera® retainers by assessing 
their biological behavioral effects as-received from the manufacturer and after retrieved 
from patients.  
Materials & Methods: In this in vitro investigation six sets (maxillary and mandibular) of 
Vivera® retainers, three as-received and three retrieved after four weeks of use by 
patients of an orthodontic postgraduate clinic, were immersed in normal saline solution 
for 14 days following different modes of sterilization. The estrogenicity assays involved 
two cell lines, namely the estrogen-sensitive MCF-7 and the estrogen-insensitive MDA-
MB-231. Following a six-day incubation with the solutions to be tested, at 
concentrations varying from 5% to 20% v/v in medium supplemented with 2% fetal calf 
serum devoid of endogenous estrogens, estrogenicity was assessed by cell counting; β-
Estradiol was used as positive control. The statistical analysis of data was performed 
with 2-way ANOVA with appliance and concentration as predictors. Differences were 
further investigated with the Tukey multiple comparison test at the 0.05 level of 
significance. 
Results: No significant MCF-7 proliferation was induced by the three samples 
compared either to the eluents from as-received retainers or to the negative control. As 
expected, β-estradiol induced a potent stimulation of MCF-7 cell proliferation, while no 
effect was observed on MDA-MB- 231 cells. 
Conclusions: Under the conditions of this experiment eluents of as-received and 
retrieved Vivera® retainers did not seem to exhibit xenoestrogenic activity. 
Clinical Significance: Vivera® retainers can be used as part-time removable oral 
appliances following manufacturer’s instructions. 
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INTRODUCTION  
Since post-orthodontic treatment changes occur due to the instability of the new 
occlusion produced by therapy but also due to growth, maturation and aging of the 
dentition throughout life, appropriate retention protocols should be used for every 
individual. 1,2 Clear, removable thermoplastic retainers belong to this category and have 
become popular. A few years ago Align Technology Inc. (San Jose, CA) introduced a 
clear overlay device marketed as the Vivera® retainer. 3 This retainer with separate 
components fits over the upper and lower dental arches and follows the same 3D 
manufacturing process used in the fabrication of Invisalign® aligners. Polyurethane is 
the basic constituent polymeric component used in Invisalign® aligners material and is 
not entirely inert since the material is affected by heat, moisture, and prolonged contact 
with oral enzymes. 4,5 The new generation of Invisalign® aligner material is SmartTrack, 
a thermoplastic polyurethane with an integrated elastomer. 6   
Some significant morphological differences have been found in the used Invisalign® 
aligners in relation to the new ones involving abrasion at the cusp tips, adsorption of 
integuments at stagnation sites, and localized calcification of the biofilm developed 
during intraoral use. 5 Similarly, their mechanical properties were adversely affected 
during intraoral aging. 7 Regarding leaching of biologically active substances, neither a 
traceable amount of substances in an ethanol aging solution after immersion of aligner 
specimens for two weeks at 23° C was detected 5 nor any cytotoxic and estrogenic 
activity of the device materials when tested in vitro were found. 4 Similarly Invisalign® 
aligners did not present any cytotoxic effect on human gingival fibroblasts, did not show 
any noticeable estrogenic effects when tested on MCF-7 breast cancer cell line, and no 
measurable Bisphenol-A (BPA) quantity release was traced in a trial of various 
orthodontic materials. 8 On the other hand, a relatively recent investigation found 
undesirable effects when epithelial cells were treated with eluates obtained from 
soaking Invisalign® plastic in saline solution. 9 This study was the first to report adverse 
effect of contact with Invisalign® plastic on oral keratinocytes. 
One crucial concern regarding the use of plastic-based materials is the leaching of 
chemical substances called xenoestrogens into the immediate environment surrounding 
the plastic. Those substances have the ability to produce a biological reaction 
comparable to that of estrogen hormones, which are capable of inducing estrogenic 
signals that modify gene expression. 10-12 One of the materials concerned is BPA, an 
important starting material for production of epoxy resins and polycarbonates, which is 
manufactured by acid catalyzed condensation of acetone and phenol. 13,14 BPA exhibits 
great similarity in structure with 17β-estradiol and may have similar effects. 11,15 The 
accumulated level of BPA in the body may vary according to the developmental stage 
and gender of the subject. According to the United States Environmental Protection 
Agency reference dose and the Food and Drug Administration’s acceptable daily intake 
dose, the presumed ‘‘safe’’ dosage is 50 μg/kg/day of BPA. 15-17 However, adverse 
effects have been documented with BPA doses below the above-mentioned daily level. 
18-21 
Vivera® retainers seem to be produced by a similar material to the one used for 
Invisalign® aligners and may be characterized by similar properties. However, in 
contrast to Invisalign® aligners, which are usually used for maximum two weeks almost 
full-time, Vivera® retainers have been designed for prolonged use, normally on a part-
time basis. This extended use could lead to degradation and possible deterioration of 
the material. A very recent report found statistically significant BPA levels in saliva in 
patients using vacuum-formed retainers. 22  
Since no investigations have dealt with the cytotoxicity and estrogenicity of Vivera® 
retainers until present such a study would be a valuable contribution to current 
knowledge.  
The null hypothesis of this study was that Vivera® retainers, either as-received or after 
retrieval from patients, have no cytotoxic or estrogenic effect. 
The aim of the present study was to investigate the cytotoxicity and estrogenicity of 
Vivera® retainers by assessing their biological behavioral effect as-received from the 
manufacturer and after retrieval from patients.  
 
MATERIALS AND METHODS 
The study sample consisted of six sets of Vivera® retainers, three as-received from the 
manufacturer and three retrieved from three consecutive patients of the Orthodontic 
Clinic, Hamdan Bin Mohammed College of Dental Medicine, Mohammed Bin Rashid 
University of Medicine and Health Sciences, Dubai, UAE, who consented to be included 
in the study. With regard to the retrieved retainers, these were retrieved after four weeks 
of 12-hour a day use. Each set consisted of a maxillary and a mandibular appliance.  
The evaluation of cytotoxicity and estrogenicity of all retainers took place in the 
Laboratory of Cell Proliferation and Ageing, Institute of Biosciences and Applications, 
National Centre for Scientific Research “Demokritos”, Athens, Greece. All retrieved 
retainers were divided in two equal parts randomly regardless of being upper or lower 
component. Each one was subjected to either mode of sterilization procedures, i.e. 
gamma-irradiation (IRR) or autoclaving (AUTOCL). The as-received retainers were 
divided into three equal parts randomly as well. Two parts were sterilized, with each part 
using one of the above-mentioned procedures, while the third part of as-received 
retainers was not subjected to any sterilization mode, so as to test the effects of the 
sterilization procedure. 
Following sterilization, all samples were immersed in sterile normal saline (NaCl 0.9% 
w/v) with each sample in different container and incubated for fourteen days at 37° C. 
Normal saline without any retainer was incubated under the same conditions in parallel, 
to be used as negative control. All retainers, which were following specific allocation and 
procedures of sterilization (Table 1), were aliquoted and kept at -20° C to maintain its 
integrity until further experimental use. Samples obtained from incubation of as-
received/unsterilized retainers (i.e. samples 2 and 4) were considered to be identical 
(Table 1). 
The estrogenicity assays involved two cell lines, i.e. the estrogen-sensitive MCF-7 and 
the estrogen-insensitive MDA-MB-231 (both from human breast adenocarcinoma), in 
order to exclude the possibility that a decreased proliferation of cells induced by the 
retainer eluent would mask a potential induction of proliferation due to estrogenicity.  
The cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented 
with 10% fetal bovine serum, at 37° C, in 5% carbon dioxide, in a humidified incubator 
and regularly subcultured by using trypsin-citrate solution. To evaluate the estrogenicity 
of the samples, the cells were plated in 48-well flat-bottomed microwells (10,000 cells 
per well) in DMEM and 10% fetal calf serum. Twenty-four hours later, the medium was 
changed to phenol-free DMEM supplemented with 2% fetal calf serum pre-treated with 
dextran-coated charcoal, along with the solutions to be tested, at concentrations 5%, 
10% and 20% v/v. β- Estradiol (βE2) was used as positive control, and normal saline 
solution was used as negative control. After six days of incubation, with medium 
renewal at day three, the cells were detached using trypsin-citrate solution and counted 
in a Z1 Beckman-Coulter counter. Assays were performed in triplicate, and the results 
were averaged. 
The statistical analysis of data was performed with 2-way analysis of variance (ANOVA) 
with appliance and concentration as predictors. Differences were further investigated 
with the Tukey multiple comparison test at the 0.05 level of significance. 
 
RESULTS 
An initial experiment was performed using samples 1-3, corresponding to as-received 
retainers, to assess the effects of the two sterilization procedures while the third one 
served as a control. As shown in Graph 1, none of the samples, at any concentration 
tested, induced the proliferation of MCF-7 cells compared to the negative control, in 
contrast to the pronounced stimulation by all three β-estradiol concentrations (within the 
physiological limits) tested. 
However, as shown in Figure 1, after gamma-irradiation, the appearance of the 
retainers was altered, acquiring a yellowish color reminiscent of the effect of ultraviolet 
light on plastic materials. Hence, it was considered that the sterilization through gamma-
irradiation could potentially damage the plastic, and autoclaving was finally chosen as 
the preferred mode of sterilization. 
Accordingly, samples 7, 10, and 12, corresponding to retrieved retainers form the three 
patients were evaluated in comparison to samples from as-received retainers (either 
autoclaved or not, i.e. samples 4 or 5). 
As shown in Graph 2, no significant MCF-7 proliferation was induced by the samples 7, 
10, and 12, compared either to the eluents from as-received retainers, i.e. 4 and 5, or to 
the negative control. As expected, β-estradiol induced a potent stimulation of MCF-7 cell 
proliferation, while no effect was observed on MDA-MB-231 cells. 
Thus, the null hypothesis was not rejected meaning that Vivera® retainers either the as-
received or after retrieved from patients demonstrated no cytotoxic or estrogenic action. 
 
DISCUSSION  
BPA’s implication in the general use of aligners has not been conclusive at the cell 
culture or analytical level, with views such as their inert profile or BPA release supported 
by studies with different methodological approaches. 23  
Since no other studies have assessed until present the cytotoxicity and estrogenicity of 
Vivera® retainers this investigation was designed to test them either in as-received or 
after use samples. The results failed to reveal any measurable adverse biological 
activity from either category, as-received or retrieved. A possible explanation could lie in 
the stability of material used for the fabrication of Vivera® retainers, which has not been 
stated as different from Invisalign® aligner material, with the latter being a polyurethane-
derived one. This material is manufactured from polyether urethanes used as raw 
material and these polymers have short rigid portions (the aromatic rings and the ureas) 
joined by short flexible ‘‘hinges’’ (the diamine linker and the CH2 group between the 
aromatic ring) and long very flexible portions (the polyether). 24 One should note that the 
chemical composition of this material as described does not contain the necessary 
ingredients to release BPA and induce its known adverse biological effects. However, it 
had been shown that some materials exhibit estrogenicity despite not containing BPA in 
their composition. 12  
In this study the incubation period was for two weeks. In the present experimental set-
up, the fact that during those two weeks, the normal saline immersion solution was left 
without being renewed should be taken into consideration. Accordingly, any effect likely 
to occur would be expected to be concentrated and amplified compared to the oral 
environment where saliva plays a role in diluting and renewing the medium as well as 
providing some protection effect. 9   
The estrogenicity of the eluent from the materials tested was measured using an 
established assay in protocol for estimating the proliferation of the estrogen-responsive 
MCF-7 cell line. These cells are known to express estrogen receptor-α, which is 
important for the proliferative effect of estrogens. It was proposed on account of its 
known intense proliferation upon exposure to very low levels of estrogens and, 
therefore, chosen for this sensitivity. 25 In addition, being of human origin the results of 
this study are more directly relevant to humans.  
On the other hand, using an estrogen insensitive cell line, MDA-MB-231 to serve as a 
sham control was essential. This sham control aided to a more precise estimation of the 
estrogenicity of the tested materials as it excluded the possibility that the estrogenic 
proliferative effect could be masked by the cytostatic and/or cytotoxic action of the 
eluents. 
17ß-estradiol is a natural hormone used in this study as a positive control, at a 
physiological concentration range. 26 This hormone is known to induce maximal 
biological effects at concentrations much lower than the levels at which all hormone 
receptors become saturated. Therefore, the lack of response to excessively high 
concentrations of effectors could be misinterpreted as lack of effect. 26 On the other 
hand, even very low hormone concentrations (10-12 M) leading to only 1% occupation of 
receptors can induce MCF-7 cell proliferation. 26 Hence, the maximum concentration of 
the eluents from retainers used in this study (20% v/v) was considered adequate for 
estrogenicity assessment.  
Including used retainers in the study was considered a strength, because it took into 
consideration the possibility that some material might react differently in the oral 
environment in terms of degradation and changes in physical and biological properties. 
The present study addressed this possibility by testing both conditions of the retainers 
namely as-received and retrieved from patients. With regard to the relatively short 
duration of the used retainers, which were retrieved after four weeks, research has 
shown an exponential release of BPA with high leaching in the first days thereafter 
followed by minimum. 27,28  
All the retrieved retainers were subjected to one of the sterilization procedures, gamma 
irradiation or autoclaving, in order to eliminate any possibility of bacterial growth 
masking the results of the estrogenicity assay. Gamma-irradiation sterilized retainers, 
samples 6, 8, 9, and 11, were then excluded from the experiment as its appearance 
was distorted, getting a yellowish color. 
This is the first study conducted for assessing the cytotoxic and estrogenic effect of this 
type of retainers. No other studies have been published dealing in a comparable way 
with the testing of the biological behavior of such material utilizing similar 
methodological processes apart from one report concerned only with as-received 
Invisalign® aligners and which produced similar results regarding the as-received 
retainers. 4  
The limitation of the current study lies in the results being based on in vitro assessment. 
However, in vivo testing cannot easily performed due ethical and practical difficulties 
involved, such as time required, difficulties in controlling the confounding variables, and 
frequent problems in interpreting the results. On the other hand, using cell cultures of 
human origin in this study is advantageous. 29  
 
CONCLUSIONS 
Based on the results of this study, which was carried out to test the cytotoxic and 
estrogenic behaviour of both as-received and retrieved Vivera® retainers, it can be 
concluded that there is no significant estrogenic activity after the incubation of both 
groups of these retainers in normal saline for two weeks at body temperature. 
 
CLINICAL SIGNIFICANCE 
Vivera® retainers can be used as part-time removable oral appliances following 
manufacturer’s instructions. 
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Figure 1. Appearance of the retainers after sterilization: Sterilized through gamma- 
irradiation (1); non-sterilized (2); and sterilized through autoclaving (3). After gamma-
irradiation, the appearance of the retainers was altered, acquiring a yellowish color 
reminiscent of the effect of ultraviolet light on plastic materials. Hence, it was considered 
that the sterilization through gamma-irradiation could potentially damage the plastic, and 
autoclaving was finally chosen as the preferred mode of sterilization. 
 
 
 
 
 
 
 
  
Table 1. Sample allocation and procedures of sterilization. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample No. Patient code Used retainer Sterilization procedure 
1 ALMFA014 No IRR 
2 ALMFA014 No No 
3 ALMAS000 No AUTOCL 
4 DOCTR000 No No 
5 DOCTR000 No AUTOCL 
6 DOCTR000 Yes IRR 
7 DOCTR000 Yes AUTOCL 
8 ALMAS000 No IRR 
9 ALMAS000 Yes IRR 
10 ALMAS000 Yes AUTOCL 
11 ALMFA014 Yes IRR 
12 ALMFA014 Yes AUTOCL 
  
 
 
 
 
 
 
 
Graph 1. Proliferation of MCF-7 vs. MDA-MB-231 cells in response to retainer eluent 
samples: effect of sterilization procedure using samples 1-3, corresponding to as-
received retainers, to assess the effects of the two sterilization procedures while the 
third one served as a control. None of the samples, at any concentration tested, induced 
the proliferation of MCF-7 cells compared to the negative control, in contrast to the 
pronounced stimulation by all three β-estradiol concentrations (within the physiological 
limits) tested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graph 2. Proliferation of MCF-7 vs. MDA-MB-231 cells in response to retainer eluent 
samples (average from two experiments). No significant MCF-7 proliferation was 
induced by the samples 7, 10, and 12, compared either to the eluents from as-received 
retainers (samples 4 and 5) or to the negative control. As expected, β-estradiol induced 
a potent stimulation of MCF-7 cell proliferation, while no effect was observed on MDA-
MB-231 cells. 
 
